Opus Genetics, Inc. (IRD)
4.29
-0.15
(-3.38%)
USD |
NASDAQ |
May 21, 16:00
4.29
0.00 (0.00%)
After-Hours: 19:59
Opus Genetics Research and Development Expense (TTM) : 33.44M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Keros Therapeutics, Inc. | 96.95M |
| Xilio Therapeutics, Inc. | 67.60M |
| ACADIA Pharmaceuticals, Inc. | 327.40M |
| Alnylam Pharmaceuticals, Inc. | 1.420B |
| Amgen, Inc. | 7.514B |